Studies have shown that abnormal methylation of BRCA1/2 genes in ovarian cancer tissue is closely associated with microbial-associated inflammation [114], further demonstrating the ability of vaginal microbiota metabolism to promote ovarian cancer development by epigenetic modifications. This evidence concerns the gene BRCA1 and ovarian carcinoma.